Biotech Jobs Could Elude Postdocs As Firms Seek Experienced Workers

Postdocs fresh from academia looking to biotechnology this spring are in for a big letdown. While postdocs once were the bread and butter of a fledgling industry, the years of their being snapped up out of school have given way to their becoming an afterthought as the field shifts its focus from innovation to commercialization of existing products under development. The recruitment focus of these companies now centers on experienced bachelor's and master's degree holders and specialized Ph.D.'s

Written byRobin Eisner
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

So say leaders of prominent biotech companies, their personnel directors, head hunters, and industry analysts of an employment phenomenon that is the result of the companies' emphasis on bringing the products such Ph.D.'s once discovered to market.

"The largest growth area for biotechnology companies in 1991 and in the next few years will be manufacturing and commercialization," says David Jensen, of Search Masters International, an executive and scientific search firm in Sedona, Ariz. The bulk of these positions will be filled with non-Ph.D. technicians and engineers who have a few years' industry experience, he says.

Other human resources specialists agree, adding that there is always a demand at biotech firms for highly skilled doctorate-level specialists, such as microbial physiologists.

"Good people are still hard to find. Often the areas we're looking into are cutting-edge, and not too many people are out there," says Chris Giffin, senior recruiter at the Thousand ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA